NCT05950997 2024-05-09A Single Arm Study of Acalabrutinib Conbimed With Obinutuzumab in Chinese Patients With Previously Untreated CLLThe First Affiliated Hospital with Nanjing Medical UniversityPhase NA Recruiting89 enrolled